Clinical Trials Insight: 700012149
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2007
At a glance
- Drugs Arimoclomol (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors CytRx Corporation
- 02 Dec 2007 Additional trial results will be presented at the 18th Symposium on ALS/MND.
- 15 Feb 2006 New trial record.